OxyContin, Purdue Pharma

That demand prompted objections because — unlike Purdue, which marketed OxyContin — none of the Sacklers themselves had filed for bankruptcy protection. Under the new terms, the Sacklers would ...
Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...